Complications of Systemic Onset Juvenile Rheumatoid Arthritis
Links shared publicly online about this topic
Rheumatology Article | Systemic juvenile idiopathic arthritis
mdlinx.com — “Monitoring serum IL-18 levels is useful for treatment of a patient with systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome” View full resource at mdlinx.com
Most Recently Shared on July 15, 2011 at 10:52 pm By:
Monitoring serum IL-18 levels is useful for treatment of a patient with systemic juvenile idiopath... http://bit.ly/nkGkuJ #Rheumatology
Juvenile Arthritis (Juvenile Rheumatoid Arthritis) Symptoms, Causes, Treatment - What is the outlook (prognosis) for children with arthritis on MedicineNet
medicinenet.com — “Read about juvenile arthritis (juvenile rheumatoid arthritis, JRA) symptoms, treatment, diagnosis, prognosis, types (systemic-onset, pauciarticular, polyarticular) and causes.” View full resource at medicinenet.com
Most Recently Shared on August 4, 2010 at 7:48 pm By:
JRA is the most common type of arthritis affecting children. Learn more about this disease: http://bit.ly/9AcqT1
Rheumatology Article | Arthritis
mdlinx.com — “Safety and efficacy of an oral histone deacetylase inhibitor in systemic onset juvenile idiopathic arthritis” View full resource at mdlinx.com
Most Recently Shared on January 22, 2011 at 1:12 am By:
Safety and efficacy of an oral histone deacetylase inhibitor in systemic onset juvenile idiopathic... http://bit.ly/hkON1M #Rheumatology
Family Medicine Article | Arthritis
mdlinx.com — “Safety and efficacy of an oral histone deacetylase inhibitor in systemic onset juvenile idiopathic arthritis” View full resource at mdlinx.com
Most Recently Shared on January 21, 2011 at 7:05 am By:
Safety and efficacy of an oral histone deacetylase inhibitor in systemic onset juvenile idiopathic ... http://bit.ly/dQZZP5 #FamPractice
Rheumatology Medical News about Arthritis, Juvenile Rheumatoid Macrophage Activation Macrophage Activation Syndrome
mdlinx.com — “Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis” View full resource at mdlinx.com
Most Recently Shared on May 21, 2010 at 6:47 pm By:
Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage acti... http://bit.ly/brt6ps #Rheumatology
Study: Actemra better than placebo in late-stage trial - Related Stories - AAP SmartBrief
smartbrief.com — “More patients who took Roche Holding's Actemra had reduced signs and symptoms of systemic onset juvenile idiopathic arthritis than those given placebo after 12 weeks of treatment in a Phase III trial. The finding adds to evidence of Actemra's efficacy for arthritis, including another late-stage stud” View full resource at smartbrief.com
Most Recently Shared on November 20, 2009 at 11:14 pm By:
Study: Actemra better than placebo in late-stage trial http://sbne.ws/r/3jBZ
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Susan Scroggins
Passionate about sharing quality health resources for good health. Content curator and organizer at organizedwisdom.com.
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
Advertisement

